PortfoliosLab logo

Sarepta Therapeutics, Inc.

SRPT
Equity · Currency in USD
ISIN
US8036071004
CUSIP
803607100
Sector
Healthcare
Industry
Biotechnology

SRPTPrice Chart


Click Calculate to get results
S&P 500

SRPTPerformance

The chart shows the growth of $10,000 invested in Sarepta Therapeutics, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $83,703 for a total return of roughly 737.03%. All prices are adjusted for splits and dividends.


SRPT (Sarepta Therapeutics, Inc.)
Benchmark (S&P 500)

SRPTReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M3.16%
YTD-53.46%
6M-54.76%
1Y-51.97%
5Y35.55%
10Y25.14%

SRPTMonthly Returns Heatmap


Click Calculate to get results

SRPTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Sarepta Therapeutics, Inc. Sharpe ratio is -0.65. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


SRPT (Sarepta Therapeutics, Inc.)
Benchmark (S&P 500)

SRPTDividends


SRPT doesn't pay dividends

SRPTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


SRPT (Sarepta Therapeutics, Inc.)
Benchmark (S&P 500)

SRPTWorst Drawdowns

The table below shows the maximum drawdowns of the Sarepta Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Sarepta Therapeutics, Inc. is 80.04%, recorded on Feb 8, 2016. It took 156 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80.04%Oct 8, 2013588Feb 8, 2016156Sep 20, 2016744
-79.07%Jan 12, 2011237Dec 19, 2011177Aug 31, 2012414
-61.18%Dec 23, 202074Apr 12, 2021
-56.01%Oct 6, 201660Dec 30, 2016264Jan 19, 2018324
-54.92%Oct 1, 2018249Sep 26, 2019182Jun 17, 2020431
-52.53%Oct 4, 201218Oct 31, 2012180Jul 22, 2013198
-35.75%Jan 21, 201053Apr 7, 201070Jul 16, 2010123
-33.43%Jul 24, 201319Aug 19, 201324Sep 23, 201343
-27.14%Jul 21, 202079Nov 9, 202028Dec 18, 2020107
-24.97%Jun 21, 201827Jul 30, 201840Sep 25, 201867

SRPTVolatility Chart

Current Sarepta Therapeutics, Inc. volatility is 43.09%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


SRPT (Sarepta Therapeutics, Inc.)
Benchmark (S&P 500)

Portfolios with Sarepta Therapeutics, Inc.


Loading data...

More Tools for Sarepta Therapeutics, Inc.